The ability of a human coreceptor to function in mice was investigated by generating human CD4 (hCD4)-expressing transgenic mice on a mouse CD4-deficient (mCD4 -/-) background. From developing thymocyte to matured T lymphocyte functions, hCD4 was shown to be physiologically active. By examining the expansion and deletion of specific V/3 T cell families in mutated mice with and without hCD4, it was found that hCD4 can participate in positive and negative selection. Mature hCD4 single positive cells also were found in the periphery and they were shown to restore MHC class II-restricted alloreactive and antigen-specific T cell responses that were deficient in the mCD4 (-/-) mice. In addition, these hCD4 reconstituted mice can generate a secondary immunoglobulin G humoral response matching that of mCD4 wild-type mice. The fact that human CD4 is functional in mice and can be studied in the absence of murine CD4 should facilitate studies of human CD4 activity in general and human immunodeficiency virus 1 gp120-mediated pathogenesis in acquired immune deficiency syndrome specifically. oc//3 T cells are primarily subdivided on the basis of the CD4 or CD8 coreceptors that they express. CD8 T cells recognize MHC dass I in conjunction with cytoplasmic peptide. Upon antigen recognition, these cells deliver effector function which leads to the killing of the cell that is recognized. In this way, these cytotoxic T cells play a major role to resistance to viral infection by the elimination of vitally infected cells. CD4 T cells recognize MHC dass II in conjunction with antigenic peptide that derives from the extraceUular compartment, or from intracellular vesicles. CD4 T cells either potentiate the inflammatory response by the synthesis of the cytokines IFN-'y, TNF-c~ and/3, and so on, whereas a second subset of CD4 T cells synthesizes the cytokines such as IL-4 and IL-5, and potentiates the humoral immune response (1, 2). The coreceptors CD4 and CD8 both interact directly with their ligands MHC dass I and II, respectively. Moreover, CD4 and CD8 interact directly with the tyrosine kinase kk via binding of this enzyme to the cytoplasmic tail of these molecules (3). In a way that is not well understood at present, this interaction contributes to the delivery of the antigen-specific fig Antibodies to these molecules block T cell development and recent studies using CD4 or CD8 deficient mice show defective development of the helper and cytotoxic T cell compartments, respectively (9, 10). Positive and negative selection of thymocytes was dysfunctional when a mutant class I molecule that was unable to bind CD8 was used as a restriction element (5). Moreover, in mice that are deficient for mouse CD4, it has also been shown that the alloreactivity to MHC class II antigen and the antibody response to a T cell-dependent soluble antigen are markedly diminished (10).
Summary
The ability of a human coreceptor to function in mice was investigated by generating human CD4 (hCD4)-expressing transgenic mice on a mouse CD4-deficient (mCD4 -/-) background. From developing thymocyte to matured T lymphocyte functions, hCD4 was shown to be physiologically active. By examining the expansion and deletion of specific V/3 T cell families in mutated mice with and without hCD4, it was found that hCD4 can participate in positive and negative selection. Mature hCD4 single positive cells also were found in the periphery and they were shown to restore MHC class II-restricted alloreactive and antigen-specific T cell responses that were deficient in the mCD4 (-/-) mice. In addition, these hCD4 reconstituted mice can generate a secondary immunoglobulin G humoral response matching that of mCD4 wild-type mice. The fact that human CD4 is functional in mice and can be studied in the absence of murine CD4 should facilitate studies of human CD4 activity in general and human immunodeficiency virus 1 gp120-mediated pathogenesis in acquired immune deficiency syndrome specifically. oc//3 T cells are primarily subdivided on the basis of the CD4 or CD8 coreceptors that they express. CD8 T cells recognize MHC dass I in conjunction with cytoplasmic peptide. Upon antigen recognition, these cells deliver effector function which leads to the killing of the cell that is recognized. In this way, these cytotoxic T cells play a major role to resistance to viral infection by the elimination of vitally infected cells. CD4 T cells recognize MHC dass II in conjunction with antigenic peptide that derives from the extraceUular compartment, or from intracellular vesicles. CD4 T cells either potentiate the inflammatory response by the synthesis of the cytokines IFN-'y, TNF-c~ and/3, and so on, whereas a second subset of CD4 T cells synthesizes the cytokines such as IL-4 and IL-5, and potentiates the humoral immune response (1, 2) . The coreceptors CD4 and CD8 both interact directly with their ligands MHC dass I and II, respectively. Moreover, CD4 and CD8 interact directly with the tyrosine kinase kk via binding of this enzyme to the cytoplasmic tail of these molecules (3) . In a way that is not well understood at present, this interaction contributes to the delivery of the antigen-specific fignalling via the TCR-MHC interaction (4) .
CD4 and CD8 are also required for the development of T cells (Kaufman-Paterson, K., L. C. Burkly, D. K. Kurahara, A. Dunlop, D. Kioussis, C. Mamalaki, K. A. Flavell, and T. H. Finkel, manuscript submitted for publication; [5] [6] [7] [8] .
Antibodies to these molecules block T cell development and recent studies using CD4 or CD8 deficient mice show defective development of the helper and cytotoxic T cell compartments, respectively (9, 10) . Positive and negative selection of thymocytes was dysfunctional when a mutant class I molecule that was unable to bind CD8 was used as a restriction element (5) . Moreover, in mice that are deficient for mouse CD4, it has also been shown that the alloreactivity to MHC class II antigen and the antibody response to a T cell-dependent soluble antigen are markedly diminished (10) .
Despite having essentially identical functions in mice and humans, the overall homology of human CD4 (hCD4) 1 to murine CD4 (mCD4) is low (11) . But upon closer inspection, the amino acid sequence critical in binding to the src tyrosine kinase p56 lck is 100% homologous. There is also functional evidence that human or mouse CD4 binds to the MHC II of the heterologous species (12) (13) (14) (15) (16) although the mCD4-human MHC interaction is weaker than the corresponding heterologous hCD4-mouse MHC interaction in vitro (17) (18) (19) . In fact, using different levels of surface hCD4
1 Abbreviations used in this paper: hCD4, human CD4; mCD4, murine CD4.
expressing transgenic mouse lines, Barzaga-Gilbert et al. (12) have shown that the human coreceptor is functional in alloreactive responses.
In light of these interspedfic interactions intracellularly and extracellularly, and the in vivo system available from mCD4 mutants, we have tested whether hCD4 can reconstitute the cellular phenotype and function ofmCD4 at the organsimal level. We, therefore, generated transgenic mice expressing hCD4 specifically in lymphocytes (H-/+), and bred them onto mice homozygous for the disrupted CD4 gene (M-/-). To facilitate the analysis of T cell development and function, we also used mice transgenic for the chick OVA-specific TCR (O-/+). We show here that human CD4 can participate in negative and positive selection of T cells and reconstitute the mature T cell subsets in mice. This reconstitution also reestablishes function as illustrated by aUoreactive and antigen-specific responses as well as T cell-dependent B cell antibody responses.
Materiah and Methods
Transgenic and Gene DisruptedMic~ The generation of the human CD4 transgenic line, 313, has been described in detail elsewhere (Kaufman-peterson, R., et al., manuscript submitted for publication). Briefly, the DNA construct for microinjection uses a 2.8-kb human CD4 eDNA fragment which is placed in an artificially produced EcoRI site of the human CD2 promoter-locus control region cassette (20, 21) . This insertion also replaces the human CD2 first exon and leaves the 5' flanking promoter and 3' flanking regulator sequences intact. The result is an expression that is construct copy number dependent and lymphocyte specific, independent of the position of integration in the mouse genome. The linearized construct was then injected into CBA/Ca x C57BL/10 fertilized eggs in the standard manner (21) . The mouse CD4-deficient line is described in Rahemtulla et al. (10) . Mice homozygous for the disrupted gene (M -/-) were bred with the hCD4 transgenic mice. The latter mice used have been backcrossed to C57BL/6J seven times before the initiation of this breeding. Additional breeding and screening of the combined heterozygous genotypes gave rise to mice that were H-/+ and M-/-, MHC haplotype b/b.
The OVA-specific, MHC class II I-An-restricted TCR transgenie line (O -/+) has been previously described (22) and was generously provided by Drs. Dennis I_oh and Kenneth Murphy (Washington University, St. Louis, MO). Briefly, this TCR transgenie construct incorporates the productive Vcz 13 and VB 8.2 chain genomic rearrangements that have been cloned from the hybridoma cell line DOl1. 10 (23, 24) . These mice were similarly crossed with the M -/-mice and the progeny screened and bred to reach the O-/+M-/-genotype. One such mouse was then bred with H-/+M -/-females to create the O-/*H-/+M -/-genotype and their respective transgene-negative littermates with the MHC haplotype b/d. We also bred the O+H-M -mouse with B6 mice to generate O + H-M-/+ mice to serve as controls in antigen-specific T cell activation and FACS | analysis (Becton Dickinson & Co., Mountain View, CA) experiments. As with the O § -mice, these M § mice are heterozygous for CD4 and MHC class II alleles (b/d).
The transgenic 107.1 line is a mouse strain with wild-type expression ofMHC II I-E generated initially on C57BL/10 mice and backcrossed onto the C57BL/6J strain (25) . C57BL/6J, C57BL/10J, and CBA/ca/J mice came from The Jackson hboratory (Bar Harbor, ME). 
T Cell Enrichment.
Freshly harvested spleens and LNs were treated as for cell preparations for FACS* analysis. 100 x 10" cells were incubated with the mouse mAb 212.A1 for 60 min at 4~ After washing in HBSS 2.5% FCS, cells were resuspended in flasks containing goat anti-mouse Ig antibody coupled to magnetic beads (Collaborative Biomedical Research, Bedford, MA). After a 45-min incubation with gentle rocking, a magnet was applied to remove the 212.A1 bound and surface Ig cells that had taken up the goat anti-mouse antibody/magnetic beads. This whole cycle of magnetic beads coupled to antibody incubation and magnet removal of cells with class II MHC and surface Ig was repeated. The field was consistently between 88 and 95% CD3 § cells with <5% contaminating cells B220 § This method of T cell enrichment was used in all the MLR and antigen-specific proliferation assays and in preparing cells for V~ staining to examine positive and negative selection.
MLR and Antigen-specific Proliferation Assays. Immediately after the T cell enrichment procedure, serial dilutions of the cells were done and plated in quadruplicates in round-bottomed 96-well phtes (Costar Corp., Cambridge, MA) in Brufl~s-gentamicin medium supplemented with 5% FCS (Hyclone Laboratories, Logan, UT). Stimulator calls for MLP, assays were B6 or transgenic 107.1 splenocytes, irradiated with Cs 139 (2,500 tad), at 5 x 10 s cells/well. For antigen-specific proliferation, irradiated self-splenocytes were used and chick OVA (Sigma Chemical Co., St. Louis, MO) was added to reach a final volume of 0.2 ml/well. Assays of alloreactivity were allowed to go 5 d with a 16-h [~H]thymidine pulse at the end. Antigen-specific proliferation went 72 h and pulsed for the same duration. Wells were harvested onto paper filters with a cell harvesting system, and counted in a beta counter (Betaplate 1502; WaUac, Gaithersburg, MD).
ELISA. 3-4-mo-old mice of the H-M-, H*M-, B6, H+M § background were immunized with 50 #g KLH (CalbiochemNovabiochem Corp., San Diego, CA) in CFA intraperitoneally. A booster in IFA was given at 3 wk and serum collectr at day 10 and week 5. KLH (20/~g/ml) in PBS was allowed to coat polyvinyl chloride 96-wall plates overnight at 4~ The phtes were washed in borate saline, blocked with 1% BSA, and incubated with increasing dilutions of serum for 2 h at 21~ After washing, goat anti-mouse total IgG (H + L) horseradish peroxidase-conjugated antibody (Bethesda Research Laboratories) was applied for I h at 21~ A 4-aminoantipyrine/phenol/HzOz solution was then used as a substrate. Calorimetric readings using a spectrophotometer (Titertek Multiscan; Flow Laboratories-ICN, Costa Mesa, CA) were taken at 20-min intervals.
Re.ul=
Expression of Human CD4 in Mice. Before assessing how hCD4 may substitute for the function of mCD4, we determined the level and distribution of hCD4 expression. As predicted by previous works using the same human hCD4 (Fig. 1, A and B) . Consistent with the fact that mufine CD2 is also expressed in some B cells, we find that hCD4 directed by the human CD2 promoter is present in about 70-80% of the B cells (Fig. 1, C and D) . This pattern of expression is maintained in the three lines of mice that carry the transgene, i.e., transgenic line 313 expressing both routine and human CD4 (H + M +), mice that have the human CD4 transgene on a background that is homozygous deficient for routine CD4 (H + M-), and finally, the latter mice also carrying a TCK transgene specific for OVA (O) in the context of bA d (O + H + M-). Hence, the presence of the OVA-TCR transgene or the absence of the mCD4 gene product does not affect the distribution or the expression of hCD4. The level of hCD4 is similar in mCD4 and CD8 positive T cells. It is interestingly to note, however, that hCD4 is expressed at a higher level in a minority of single positive T cells that lack mCD4 (CD3+hCD4+CDS-) when compared (Fig. 2 , A-C and see below). Finally, we also compared the expression level of the trans-gene to its natural endogenous counterpart in human PBMC. Fig. 2 A shows that surface hCD4 expression is at least five times higher in human cells than in transgenic mouse cells.
Reconstitution of the T-lymphocyte Subsets. As reported by
Rahemtnlla (10), 90% of the T cells in the periphery of the M-mice are CD8 + and 10% are CD3+CD4-CD8 -. This disproportionate shift of single positive cells to the CD8 + phenotype is corrected by hCD4. Fig. 3 shows the reconstitution of hCD4 single positive ceils. In the H+M -mice, the CD3 § ceils are composed of 56% CD8 + cells and >40% hCD4 single positive ceils (Fig. 3 A) . Human CD4, therefore, permits approximately fourfold more T calls to be selected for MHC class II recognition. As we will show below, these hCD4 § T cells are also functional in T cell assays. To confirm this observation and because B cdl contamination can increase the apparent number of hCD4 + CD8-cells, we performed three-color staining using anti-CD8, B220, and hCD4 antibodies with gating on the CD8-/B220-population; this showed the same percentage of hCD4 + cells (data not shown). The rescue ofCD4 T cells by hCD4 transgene expression is still greater in the TCR transgenic mice. Most CD3 + cells (>70%) are hCD4-CD8-, and 25% are CD3+CD8 + in the O+H+M -mice, as shown by Fig. 3 B.
Likewise, in the OVA-TCR transgenic with mCD4, the percentage of CD4 cells is even higher, reaching 82% of all CD3 + cells (Fig. 3 C) . It is also to be noted that the gross appearance of the thymus, LNs, and spleen was normal in these various lines of transgenic and/or mutated mice. The total number of ceils in the spleen and its absolute number of T cells (CD3 +) and B calls (B220 +) was not altered significantly as compared with B6 mice of a similar age (data not shown). To compare the quantitative effectiveness of hCD4 in posifive and negative selection in mice that are defident in mCD4, we focused specifically on the mature peripheral CD3 + CD8-subset. In mice expressing human or mouse CD4 coreceptors, these cells are all CD3+CD4 +. In the O-H-M-mice, however, these cells (CD3+CD4-CD8 -) had no coreceptors and consisted only of 10-15% of the CD3 + ceils. They were compared with the CD3 + HCD4 + CD3 -cells of the O -H + M -mice. In the O-H + M -mice, this is the hCD4 single positive subset which increased to 40-45% of the CD3 + cells. Additionally, we used mCD4 single positive calls from B6 mice (I=E b negative) and B6 mice expressing an I-E transgene (transgenic line 107.1, I=E +) as controls.
Human CD4 Redirects
Vfl6 + CD4 T cells are positively selected by I=E and as a result show an elevated percentage in I=E + mouse strains (31) . V~/6 + CD4 ceils (see Fig. 5 B) account for 7.85% in B6 mice that lack the I-E selecting dement but increase to 11.45% of the CD3+mCD4 + subpopulation in the syngeneic I-E + 107.1 mice. This number falls to 7.79% in the O-H-M-mice lacking CD4 (the same level seen without I-E in the control B6 mice), despite the presence of I-E. HCD4 reconstitutes this V~6 population to 10.35% in the O-H+M -mice, showing that as determined by this assay, hCD4 can function equally well in positive selection as the endogenous murine CD4 gene.
We also examined the positive selection of OVA-TCR cells in the mCD4=defident background. The selection of the OVA-TCR clonotype does not absolutely require CD4. Thus, in the CD8-subset (which is also CD4-) of the O+H-Mmice which comprises 10-15% of the CD3 + calls, 52% express the OVA-TCR donotype (Fig. 4 C) . Of the 85-90% of the remaining CD3 + cells that are CD4-CD +, 50% are 
(D and E) This
CD8-subpopuhtion is also CD4-and occupies only 12-15% of the T lymphocyte compartment but, is largely restored in the hCD4 mice. Samples used for staining came from LN and spleen and enriched for the T cell fraction. Three-color staining was then performed using combinations of conjugated antibodies as described in Materials and Methods. The total number of ceils in the spleen as well as the absolute numbers oft and B ceils in this organ were not found to be significantly different among these mouse lines. clonotypic (data not shown). However, the presence of either human or mouse CD4 not only increases the size of the CD3+CD8 -subset itself but also that of the CD8-subpopulation (which is CD4 +) which is donotypic. For example, the percentage of CD4 single positive cells increased from '~60% (data not shown) to 82% in the O+H-M + mice (Fig. 3 C) , and from 44% (O-M+M -) to 75% in the O+H+M -mice (Fig. 3, A and B) . Furthermore, within this CD8 negative or CD4 single positive population, >70 and 80% (vs 52% in mice lacking CD4) are clonotypic in the O + H-M + and O + H + M -mice, respectively (Fig. 4, A  and B ). VB5 and Vi~11 T cells are ddeted in mice that express a functional I-E molecule in conjunction with the endogenous retroviruses MMTV (mouse mammary tumor virus) 6, 8, and 9 (32, 33) . To address whether hCD4 can participate in and influence negative selection, we therefore determined the percentage of V/35 and VBll T cells in the periphery (Fig. 5, D and F) . The percentage of V/~5/CD8-or CD4 + and VBll/CD8-or CD4 + cells in I-E + 107.1 transgenic mice was 0.64 and 0.39%, respectively, in the presence of mCD4. In the O-H + M-mice, hCD4 maintains this deletion at 0.75% (V~5) and 1.5% (VBll). In the O-H-Mmice, we used the CD3+CD4-CD8 -population as the corresponding subset to compare with the mouse or human CD4 single positive subset. For VBS, it consisted of 2.12%, and for Vl~11, 3.56% of the double negative peripheral T cells despite the presence of I-E. In the absence of I-E but in the presence of mCD4 as in the B6 mouse strain (which is syngeneic to strain 107.1), it is 3.58 and 4.98% for Vl~5 and V~11, respectively. The intermediate level seen in the O-H-M-mice suggests that although CD4 enhances the negative selection of these V~ families in the presence of I-E, it is not mandatory. It is possible that the affinity of the interaction between some VB TCRs and their class II ligand is such that coreceptor assistance is not necessary in the deletion process. It is interesting to note that consistent with this observation, deletion of both V1311 and more strikingly, VI~5, also occurs in the CD8 T cells of mice without human and mouse CD4 (O-H-M-). The deletion of these cells was thought to be due to the interaction of CD4 with MHC class II during the double positive stage of the thymocyte development (34, 35) . It is 3.05% for VB5 and 4.57% for VBll, a level significantly lowe~ than that seen in the B6 strain (12.55 and 7.15%, respectively), and nearly matches the percentages seen in the transgenic 107.1 and O-H § M-strains (Fig. 5, C and E) . This finding again suggests that there is not an absolute requirement for CD4 for the recognition of superantigen during T cell development.
Human CD4 Participates in Alloreactivity and Antigen-specific
Response. In attempting to define the role of hCD4 in the mouse T cell response, we first set up a primary mixed lymphocyte response disparate in a single MHC class II I-E antigen. This was achieved by using the I-E~ a transgenic 107.1 line bred onto the B6 background. Serially diluted responder cells from 88-95% T cell-enriched preparations were set up with irradiated stimulator cells provided by 107.1 or B6 splenocytes (Fig. 6) . The responsiveness of the H+M -cells matched that of the T cells from the B6 and transgenic 313 line (H+M+), whereas that of the H-M-cells is markedly diminished. Similarly, Killeen et al. (36) also showed restoration of alloreactivity to an MHC class II antigen (H-2 bm12) when a human CD4 transgene was expressed in a different mouse CD4-deficient line (see Discussion).
Since CD4 should also potentiate T cell activation to processed soluble antigen presented by MHC II molecules, we used the O + H + M-mice to test whether T cell proliferation to antigen is restored. When irradiated splenocytes were fed OVA and incubated with T-enriched unprimed cells from either O-H-M +, O § + (product of the B6/O+M -cross), O+H+M -or O+H-M -mice, there was again a marked enhancement of proliferation in the OVA-TCR hCD4 + and mCD4 + cells (Fig. 7) . When a fixed number of cells were incubated with increasing amounts of antigen, a similar pattern of difference in responsiveness was also seen (data not shown). 
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Figure 7. The response of various OVA TCIL transgenic lines to OVA. The response of serially diluted unprimed T-enriched cells to OVA was assessed by proliferation or thymidine incorporation after incubation with irradiated O-syngeneic splenocytes and 100 #g/ml of antigen for 3 d. Cells were incubated in triplicate wells and the data shown here is representative of three other experiments using additional mice. When the coneent-radon of antigen was serially diluted and the stimulators and responders were kept constant, a similar pattern and difference in response was seen. interaction, mice were immunized with KLH, a T celldependent antigen, boosted, and the secondary antibody response analyzed by an antibody capture ELISA (Fig. 8) . Although the mice without CD4 still mounted a modest response, the control B6 and experimental H+M -mice produced a specific IgG response at least three times larger. Another experiment using two mice from each group and including the 313 transgenic line (H+M+), produced similar results with the 313 response matching that of the B6 and H *M-mice (data not shown). These observations are consistent with studies of Killeen et al. (36) , who showed that primary antibody responses to TNP-KLH are reconstituted in CD4-deficient mice carrying the human CD4 transgene.
Discussion
In this paper we present evidence that the human T cell coreceptor, hCD4, is functional in T cell development and T cell function in mice. In mice that are deficient in mCD4, CD8 + lymphocytes occupy 90% of the peripheral T cell compartment. The expression of hCD4 in these mice restores the CD4 single positive population to 40-45%, facilitates positive and negative selection in the thymus, and hCD4 functions in T cell activation in vitro and T cell help in vivo. Using a mCD4 enhancer and the human CD4 promoter, Killeen et al. (36) recently observed a restoration of 70% when hCD4 is expressed as a transgene in mCD4-deficient mice. The larger percentage (70 vs 40--45%) of restored single positive CD4 T cells in the latter system is most likely due to the higher expression level of hCD4. Despite the fact that the expression level is somewhat lower in our system, functional reconstitution is obtained.
To establish functionality of hCD4 in our mouse system, we first looked at thymic selection. HDC4 participates in negative sdection of V35 and VEll cells that are deleted in the context of MHC II I-E and "self ~' superantigen. This process is defective in the H-M-thymus, but is restored for the CD4 lymphocytes of the V35 and Vflll families in the H + M-mice, since the percentages of these V/3 clones in the periphery of the reconstituted mice (O-H+M -) nearly match those of the I-E-expressing M + transgenic mice (line 107.1). In addition, this effect carries over to the CD8 subset because hCD4 is also present in the CD8 + cells in the O-H + M-transgenic mice which causes a further deletion of the CD8 + V/35 and V311 cells. Moreover, deletion of CD8 + V/35 and V/311 T cells also occurs to some extent in the H-M-thymus despite the absence of CD4. Previously it was considered that the deletion of these CD8 T ceils by MHC class II presented superantigen occurred at the double positive CD4+CD8 + stage and was therefore mediated by CD4 (34, 35) . Our finding here confirms the observation of Wallace et al. (37) who also examined the negative selection of CD8 cells with other strains of mice and different V3 families. That is, it is possible that CD4 may not be absolutely necessary for deletion of some V/3 groups. Alternatively, this deletion can occur at a stage other than the double positive cell stage at which CD4 can exert an effect. Hence, negative selection of certain V3 families may not absolutely require CD4 but it is enhanced in the presence of CD4. For positive selection, we examined V/~6 T cells selected by I-E, and the OVA-specific TCR transgenic T cells selected by I-A a. Again, we observed the percentage of V~6 CD4 cells in the O-H+M -mice (10.35%) to be above the I-E-B6 control (7.85%), and equivalent to the 1-E-expressing transgenic 107.1 control (11.45%). The OVA-specific T cells are strongly positively selected in hCD4-expressing mice comprising •82% of peripheral hCD4 single positive T cells in O+H+M -mice, vs. a similarly large 73% in the O+H-M + mice. The reason why a slightly higher percentage is actually seen in the O +H+M-mice is not clear.
Recent work (Kaufman-Paterson et al., manuscript submitred for publication, and 38, 39) using transgenic and genedeficient mice has provided new evidence supporting the stochastic model of positive selection. According to this model (40, 41) , a developing T cell with a TCtL that is class II restricted goes through a stage where either CD8 or CD4 is randomly turned off. At this intermediate stage, ff CD4 is present and the TCK engages its cognate dass II ligand, then this cell will have been successfully sdected for maturation. Since hCD4 is constitutively expressed in the CD8 + ceils in our transgenic mice, we have asked whether this affects the unusually large percentage of CD8 calls that proceeds through positive selection. For example, hCD4 may not only rescue the CD3+CD8 -MHC class II-restricted T cell population but also those cells that are CD3+CD8 + that would not have been selected.
In the V~ sdection of our O-H+M -mice that are I-E + and have CD4 on CD8 + cells, small effects on the CD8 + subset can be observed. First, the percentage of V/35 and Vflll CD8 + cells from these mice is lower than that in the transgenie 107.1 mice (Fig. 5 , C and E), suggesting that negative selection in this population has been aided by the presence of hCD4. Similarly, the percentage of Vfl6 CD8 + cells is slightly higher in the O-H+M -than in the transgenic 107.1 mice (Fig. 5 A) . The small increase of V/36 CD8 + cells in the O-H+M -mice could suggest a rescue effect provided by hCD4 and hence be consistent with the stochastic model of positive selection. To directly assess whether the CD4+CD8 + cells were selected by MHC class II and to test the stochastic model functionally, we can take advantage of our transgenic/mutated mouse system by sorting for OVA-TCK+CD4+CD8 + ceils and compare their response to OVA with OVA-TCR + human or mouse CD4 single positive cells. This work is in progress.
Finally, we have also provided evidence that the restoration of the CD4 single positive phenotype is functional at the level of the mature T cell. That is, cells from H+M -mice respond markedly better to allo-MHC class II than H-M-cells in a primary class II disparate MLR and, respond better in an antigen-specific manner when the OVA-TCR mice are used. Both responses dosely match that of the mCD4 wild type. In addition, T cell hdp is restored in H + M-mice since good levels of antibodies to KLH are obtained after immunization in both primary (36) and secondary antibody responses as shown in our study.
Mice with targeted disruptions of a given gene should not only allow the exploration of the function of the defective gene, but should also make possible refined animal modds to study human physiology or disease. There is strong evidence to suggest the CD4 cell dysfunction and perhaps loss in HIV-1 infection is in part due to indirect mechanisms mediated by Env gpl20-CD4 interactions (42) (43) (44) (45) (46) . Certain antoimmune diseases may also involve the interaction between CD4 and predisposing HLA ligands. Since human CD4 is functional in transgenic mice, mice that express a physiologically active human CD4 replacing its murine counterpart may provide a useful model to study these problems.
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